Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Mitomycin-C 0.02% application for 12 seconds after PRK effective in preventinghaze
Mitomycin-C 0.02% applied after PRK for only 12 seconds appears to besafe and effective in preventing corneal haze in high-risk cases of ablationsgreater than 70 microns, reported Shawn R. Klein, MD, during the AmericanSociety of Cataract and Refractive Surgery (ASCRS) annual meeting.
Related Videos
Related Content
